Effects of SHP465 mixed amphetamine salts in adults with ADHD in a simulated adult workplace environment

References

• Barkley RA, Fischer M, Smallish L, et al. The persistence of attention-deficit/hyperactivity disorder into young adulthood as a function of reporting source and definition of disorder. J Abnorm Psychol. 2002;111:279–289.
   PubMed Web of Science ®Google Scholar
• Faraone SV, Biederman J, Mick E. The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies. Psychol Med. 2006;36:159–165.
   PubMed Web of Science ®Google Scholar
• Lara C, Fayyad J, De Graaf R, et al. Childhood predictors of adult attention-deficit/hyperactivity disorder: results from the World Health Organization World Mental Health Survey Initiative. Biol Psychiatry. 2009;65:46–54.
   PubMed Web of Science ®Google Scholar
• Barkley RA, Cunningham CE, Gordon M, et al. ADHD symptoms vs. impairment: revisited. ADHD Rep. 2006;14:1–9.
   Google Scholar
• De Graaf R, Kessler RC, Fayyad J, et al. The prevalence and effects of adult attention-deficit/hyperactivity disorder (ADHD) on the performance of workers: results from the WHO World Mental Health Survey Initiative. Occup Environ Med. 2008;65:835–842.
   PubMed Web of Science ®Google Scholar
• Biederman J, Faraone SV, Spencer TJ, et al. Functional impairments in adults with self-reports of diagnosed ADHD: a controlled study of 1001 adults in the community. J Clin Psychiatry. 2006;67:524–540.
   PubMed Web of Science ®Google Scholar
• Fredriksen M, Dahl AA, Martinsen EW, et al. Childhood and persistent ADHD symptoms associated with educational failure and long-term occupational disability in adult ADHD. Atten Defic Hyperact Disord. 2014;6:87–99.
   PubMedGoogle Scholar
• Kessler R, Adler L, Ames M, et al. The prevalence and effects of adult attention deficit/hyperactivity disorder on work performance in a nationally representative sample of workers. J Occup Environ Med. 2005;47:565–572.
   PubMed Web of Science ®Google Scholar
• Castle L, Aubert RE, Verbrugge RR, et al. Trends in medication treatment for ADHD. J Atten Disord. 2007;10:335–342.
   PubMedGoogle Scholar
• McGough JJ. Treatment controversies in adult ADHD. Am J Psychiatry. 2016;173:960–966.
   PubMed Web of Science ®Google Scholar
• Glenngard AH, Hjelmgren J, Thomsen PH, et al. Patient preferences and willingness-to-pay for ADHD treatment with stimulants using discrete choice experiment (DCE) in Sweden, Denmark and Norway. Nord J Psychiatry. 2013;67:351–359.
   PubMed Web of Science ®Google Scholar
• Sabate E. Adherence to long-term therapies: policy for action. Geneva, Switzerland: World Health Organization; 2001.
   Google Scholar
• Brown TE. Executive functions and attention deficit hyperactivity disorder: implications of two conflicting views. Int J Disability, Development, Educ. 2006;53:35–46.
   Google Scholar
• McCarthy S. Pharmacological interventions for ADHD: how do adolescent and adult patient beliefs and attitudes impact treatment adherence? Patient Prefer Adherence. 2014;8:1317–1327.
   PubMed Web of Science ®Google Scholar
• Brams M, Moon E, Pucci M, et al. Duration of effect of oral long-acting stimulant medications for ADHD throughout the day. Curr Med Res Opin. 2010;26:1809–1825.
   PubMed Web of Science ®Google Scholar
• Thomas M, Rostain A, Prevatt F. ADHD diagnosis and treatment in college students and young adults. Adolesc Med State Art Rev. 2013;24:659–679.
   PubMedGoogle Scholar
• Jain R, Katic A. Current and investigational medication delivery systems for treating attention-deficit/hyperactivity disorder. Prim Care Companion CNS Disord. 2016;18(4). DOI:10.4088/PCC.16r01979
   Google Scholar
• Hodgkins P, Sasane R, Christensen L, et al. Treatment outcomes with methylphenidate formulations among patients with ADHD: retrospective claims analysis of a managed care population. Curr Med Res Opin. 2011;27(suppl 2):53–62.
   PubMed Web of Science ®Google Scholar
• Setyawan J, Hodgkins P, Guerin A, et al. Comparison of therapy augmentation and deviation rates from the recommended once-daily dosing regimen between LDX and commonly prescribed long-acting stimulants for the treatment of ADHD in youth and adults. J Med Econ. 2013;16:1203–1215.
   PubMedGoogle Scholar
• Ermer JC, Shojaei A, Pennick M, et al. Bioavailability of triple-bead mixed amphetamine salts compared with a dose-augmentation strategy of mixed amphetamine salts extended release plus mixed amphetamine salts immediate release. Curr Med Res Opin. 2007;23:1067–1075.
   PubMed Web of Science ®Google Scholar
• Spencer TJ, Adler LA, Weisler RH, et al. Triple-bead mixed amphetamine salts (SPD465), a novel, enhanced extended-release amphetamine formulation for the treatment of adults with ADHD: a randomized, double-blind, multicenter, placebo-controlled study. J Clin Psychiatry. 2008;69:1437–1448.
   PubMed Web of Science ®Google Scholar
• Frick G, Yan B, Adler LA. Triple-bead mixed amphetamine salts (SHP465) in adults with attention-deficit/hyperactivity disorder: results of a phase 3, double-blind, randomized, forced-dose trial. J Atten Disord. 2017. e-publication ahead of print. DOI:10.1177/1087054717696771
   Web of Science ®Google Scholar
• Weisler RH, Greenbaum M, Arnold V, et al. Efficacy and safety of SHP465 mixed amphetamine salts in the treatment of attention-deficit/hyperactivity disorder in adults: results of a randomized, double-blind, placebo-controlled, forced-dose clinical study. CNS Drugs. 2017;31(8):685–697.
   PubMed Web of Science ®Google Scholar
• Adler LA, Goodman DW, Kollins SH, et al. Double-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder. J Clin Psychiatry. 2008;69:1364–1373.
   PubMed Web of Science ®Google Scholar
• Adler LA, Zimmerman B, Starr HL, et al. Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation study. J Clin Psychopharmacol. 2009;29:239–247.
   PubMed Web of Science ®Google Scholar
• Weisler RH, Biederman J, Spencer TJ, et al. Mixed amphetamine salts extended-release in the treatment of adult ADHD: a randomized, controlled trial. CNS Spectr. 2006;11:625–639.
   PubMed Web of Science ®Google Scholar
• Wigal T, Brams M, Gasior M, et al. Randomized, double-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: novel findings using a simulated adult workplace environment design. Behav Brain Funct. 2010;6:34.
   PubMed Web of Science ®Google Scholar
• Wigal SB, Wigal TL. The laboratory school protocol: its origin, use, and new applications. J Atten Disord. 2006;10:92–111.
   PubMedGoogle Scholar
• McCracken JT, Biederman J, Greenhill LL, et al. Analog classroom assessment of a once-daily mixed amphetamine formulation, SLI381 (Adderall XR), in children with ADHD. J Am Acad Child Adolesc Psychiatry. 2003;42:673–683.
   PubMed Web of Science ®Google Scholar
• Swanson JM, Wigal S, Greenhill LL, et al. Analog classroom assessment of Adderall in children with ADHD. J Am Acad Child Adolesc Psychiatry. 1998;37:519–526.
   PubMed Web of Science ®Google Scholar
• Wigal SB, Wigal T, Childress A, et al. The time course of effect of multilayer-release methylphenidate hydrochloride capsules: a randomized, double-blind study of adults with ADHD in a simulated adult workplace environment. J Atten Disord. 2016. e-publication ahead of print. DOI:10.1177/1087054716672335.
   PubMed Web of Science ®Google Scholar
• World Medical Association. World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects. Bull World Health Organ. 2001;79:373–374.
   PubMed Web of Science ®Google Scholar
• First M, Spitzer R, Gibbon M, et al. Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I), Clinician Version. Arlington, VA: American Psychiatric Publishing; 1997.
   Google Scholar
• Naugle RI, Chelune GJ, Tucker GD. Validity of the Kaufman Brief Intelligence Test. Psychol Assessment. 1993;5:182.
   Google Scholar
• Buysse DJ, Reynolds CF 3rd, Monk TH, et al. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28:193–213.
   PubMed Web of Science ®Google Scholar
• Backhaus J, Junghanns K, Broocks A, et al. Test-retest reliability and validity of the Pittsburgh Sleep Quality Index in primary insomnia. J Psychosom Res. 2002;53:737–740.
   PubMed Web of Science ®Google Scholar
• Manor I, Vurembrandt N, Rozen S, et al. Low self-awareness of ADHD in adults using a self-report screening questionnaire. Eur Psychiatry. 2012;27:314–320.
   PubMed Web of Science ®Google Scholar
• Knouse LE, Bagwell CL, Barkley RA, et al. Accuracy of self-evaluation in adults with ADHD: evidence from a driving study. J Atten Disord. 2005;8:221–234.
   PubMedGoogle Scholar
• Hoza B, Gerdes AC, Hinshaw SP, et al. Self-perceptions of competence in children with ADHD and comparison children. J Consult Clin Psychol. 2004;72:382–391.
   PubMed Web of Science ®Google Scholar
• Spencer TJ, Adler LA, McGough JJ, et al. Efficacy and safety of dexmethylphenidate extended-release capsules in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry. 2007;61:1380–1387.
   PubMed Web of Science ®Google Scholar